ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,458.92
      -0.19%
      US Tech 100
      19,222.80
      0.25%
      Dow Jones
      38,967.72
      -0.37%
      Brent Oil
      84.17
      -0.02%
      Bitcoin
      61,552.50
      -0.42%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Gentium Spa Ads (GNT)

      7. Gentium Spa Ads (GNT) News

      GNT

      Gentium Spa (GNT)

      Gentium Spa Ads
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:GNT
      DateTimeSourceHeadlineSymbolCompany
      2:09PMiHub NewswireFeaturedPOET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program
      05/16/20068:00AMBusiness WireGentium Begins Trading on NASDAQ; New Ticker Symbol: GENTAMEX:GNTGentium Spa Ads
      05/05/20068:42AMBusiness WireGentium to Trade on NASDAQ National MarketAMEX:GNTGentium Spa Ads
      04/13/20066:00AMBusiness WireGentium Reports 2005 Financial Results; Provides Financial and Clinical UpdateAMEX:GNTGentium Spa Ads
      03/28/20068:00AMBusiness WireGentium Receives First IRB Approval to Begin U.S. Phase III Trial with Defibrotide to Treat Veno-Occlusive Disease with MultiplAMEX:GNTGentium Spa Ads
      02/02/20068:00AMBusiness WireGentium to Present at Angiogenesis in Cancer and Vascular Disease Congress; Defibrotide Has Anti-Angiogenic Properties In VitroAMEX:GNTGentium Spa Ads
      01/30/20068:00AMBusiness WireGentium's Defibrotide Subject of Independent Study in Japan; First Japanese Study Reports That Defibrotide Shows Success TreatinAMEX:GNTGentium Spa Ads
      01/20/20067:30AMBusiness WireGentium Initiates Phase II/III Pediatric Trial with Defibrotide to Prevent Veno-Occlusive Disease; European Group for Blood andAMEX:GNTGentium Spa Ads
      11/15/20057:00AMBusiness WireGentium Reports Third Quarter Financial Results; Provides Financial and Clinical UpdateAMEX:GNTGentium Spa Ads
      11/07/200510:12AMBusiness WireGentium to Present at Rodman & Renshaw Techvest Seventh Annual Healthcare ConferenceAMEX:GNTGentium Spa Ads
      10/17/20056:00AMBusiness WireGentium Completes $10.9 Million Private PlacementAMEX:GNTGentium Spa Ads
      10/04/20059:23AMBusiness WireGentium Raises $10.9 Million in Private Offering; Funding to Support New Trials and Continued Development of PipelineAMEX:GNTGentium Spa Ads
      09/21/20056:00AMBusiness WireGentium S.p.A. Announces Initiation of Independent Phase I/II Study of Defibrotide to treat Multiple MyelomaAMEX:GNTGentium Spa Ads
      09/15/20054:00AMBusiness WireRenowned Bone Marrow Transplantation Expert Richard E. Champlin, M.D., Joins Gentium's Scientific Advisory BoardAMEX:GNTGentium Spa Ads
      09/07/20054:00AMBusiness WireGentium S.p.A. Announces Intention to Commence Phase III Trial Following Discussions with FDAAMEX:GNTGentium Spa Ads
      08/10/20054:00AMBusiness WireGentium Reports Second Quarter Financial Results, Provides Clinical UpdateAMEX:GNTGentium Spa Ads
      08/09/20054:00AMBusiness WireGentium Presented Laboratory Data at XXth Congress of International Society for Thrombosis and Haemostasis; Laboratory Data PresAMEX:GNTGentium Spa Ads
      07/13/20054:05PMBusiness WireGentium S.p.A. Announces FDA Agrees Company's CMC Submission is Adequate for Commencing Phase III Clinical Trials with DefibrotiAMEX:GNTGentium Spa Ads
      06/16/20056:10PMPR Newswire (US)American Stock Exchange Lists American Depository Shares Representing Ordinary Shares Of Gentium S.p.ANYSE:GNT
       Showing the most relevant articles for your search:AMEX:GNT